Inhibikase Therapeutics Statistics Share Statistics Inhibikase Therapeutics has 74.34M
shares outstanding. The number of shares has increased by 895.99%
in one year.
Shares Outstanding 74.34M Shares Change (YoY) 895.99% Shares Change (QoQ) 7.18% Owned by Institutions (%) 50.62% Shares Floating 45.51M Failed to Deliver (FTD) Shares 9,892 FTD / Avg. Volume 3.94%
Short Selling Information The latest short interest is 3.07M, so 4.13% of the outstanding
shares have been sold short.
Short Interest 3.07M Short % of Shares Out 4.13% Short % of Float 10.24% Short Ratio (days to cover) 22.26
Valuation Ratios The PE ratio is -2.8 and the forward
PE ratio is -3.33.
Inhibikase Therapeutics's PEG ratio is
0.04.
PE Ratio -2.8 Forward PE -3.33 PS Ratio 0 Forward PS 13 PB Ratio 0.81 P/FCF Ratio -4.02 PEG Ratio 0.04
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Inhibikase Therapeutics.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 26.37,
with a Debt / Equity ratio of 0.
Current Ratio 26.37 Quick Ratio 26.37 Debt / Equity 0 Debt / EBITDA n/a Debt / FCF -0.01 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-1.83M Employee Count 15 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by 14.39% in the
last 52 weeks. The beta is 0.91, so Inhibikase Therapeutics's
price volatility has been higher than the market average.
Beta 0.91 52-Week Price Change 14.39% 50-Day Moving Average 1.83 200-Day Moving Average 2.31 Relative Strength Index (RSI) 35.73 Average Volume (20 Days) 251,264
Income Statement
Revenue n/a Gross Profit n/a Operating Income -28.59M Net Income -27.52M EBITDA -27.49M EBIT -27.52M Earnings Per Share (EPS) -1.16
Full Income Statement Balance Sheet The company has 56.49M in cash and 110.52K in
debt, giving a net cash position of 56.38M.
Cash & Cash Equivalents 56.49M Total Debt 110.52K Net Cash 56.38M Retained Earnings -94.42M Total Assets 94.28M Working Capital 85.61M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -19.15M
and capital expenditures 0, giving a free cash flow of -19.15M.
Operating Cash Flow -19.15M Capital Expenditures n/a Free Cash Flow -19.15M FCF Per Share -0.81
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
Dividends & Yields IKT does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for IKT is $8,
which is 429.8% higher than the current price. The consensus rating is "Hold".
Price Target $8 Price Target Difference 429.8% Analyst Consensus Hold Analyst Count 2
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Jun 30, 2023. It was a
backward
split with a ratio of 1:6.
Last Split Date Jun 30, 2023 Split Type backward Split Ratio 1:6
Scores Altman Z-Score 5.82 Piotroski F-Score 2
